In the last trading session, 9.89 million shares of the Eledon Pharmaceuticals Inc (NASDAQ:ELDN) were traded, and its beta was 0.88. Most recently the company’s share price was $3.59, and it changed around $0.22 or 6.53% from the last close, which brings the market valuation of the company to $142.38M. ELDN currently trades at a discount to its 52-week high of $3.65, offering almost -1.67% off that amount. The share price’s 52-week low was $1.07, which indicates that the current value has risen by an impressive 70.19% since then. We note from Eledon Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 1.09 million shares, with the 3-month average coming to 67.30K.
Eledon Pharmaceuticals Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended ELDN as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Eledon Pharmaceuticals Inc is expected to report earnings per share of -0.31 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Eledon Pharmaceuticals Inc (NASDAQ:ELDN) trade information
Instantly ELDN has showed a green trend with a performance of 6.53% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 4.12 on recent trading dayincreased the stock’s daily price by 12.86%. The company’s shares are currently up 99.44% year-to-date, but still up 13.43% over the last five days. On the other hand, Eledon Pharmaceuticals Inc (NASDAQ:ELDN) is 44.18% up in the 30-day period. We can see from the shorts that 0.14 million shares have been sold at a short interest cover period of 2.2 day(s).
Eledon Pharmaceuticals Inc (ELDN) estimates and forecasts
Eledon Pharmaceuticals Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 50.21 percent over the past six months and at a 7.32% annual growth rate that is well below the industry average of 17.50%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 11.40% in revenue this quarter, and will report a decrease of -6.90% in the next quarter.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 29.97%.
ELDN Dividends
Eledon Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in November.
Eledon Pharmaceuticals Inc (NASDAQ:ELDN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.07% of Eledon Pharmaceuticals Inc shares, and 46.06% of them are in the hands of institutional investors. The stock currently has a share float of 46.09%. Eledon Pharmaceuticals Inc stock is held by 37.0 institutions, with BVF INC/IL being the largest institutional investor. By 2024-06-30, it held 20.985% of the shares, which is about 6.29 million shares worth $16.61 million.
ARMISTICE CAPITAL, LLC, with 7.7894% or 2.34 million shares worth $6.17 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
